ProQR to Present at Two Upcoming Investor Conferences in March
March 01 2017 - 7:00AM
ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to
changing lives through the creation of transformative RNA medicines
for the treatment of severe genetic rare diseases including cystic
fibrosis (CF), Leber's congenital amaurosis Type 10 (LCA 10) and
dystrophic epidermolysis bullosa (DEB), today announced that Daniel
de Boer, Chief Executive Officer, and Smital Shah, Chief Financial
Officer, will present during two upcoming investor conferences this
month.
A presentation will be given during the Cowen and Company 37th
Annual Health Care Conference on Wednesday, March 8, 2017 at
10:00am ET. The conference is being held at the Boston Marriott
Copley Place in Boston, MA, USA.
The company will also present during the Barclays Global
Healthcare Conference on Wednesday, March 15, 2017 at 10:45am ET.
The conference is being held at the Loews Miami Beach Hotel in
Miami, FL, USA.
The live and archived webcast of both presentations will be
accessible from the ‘Investor Relations’ section of ProQR’s website
(www.proqr.com) under ‘Events and Presentations’. The archived
webcasts will be available for 30 days following the presentation
date.
About ProQR
ProQR Therapeutics is dedicated to changing lives through
the creation of transformative RNA medicines for the treatment of
severe genetic rare diseases such as cystic fibrosis, Leber’s
congenital amaurosis Type 10 and dystrophic epidermolysis
bullosa. Based on our unique proprietary RNA repair platform
technologies we are growing our pipeline with patients and loved
ones in mind. *Since 2012*
Contact: Sariette Witte Investor Relations T:
+1 213 261 8891 ir@proqr.com
ProQR Therapeutics NV (NASDAQ:PRQR)
Historical Stock Chart
From Aug 2024 to Sep 2024
ProQR Therapeutics NV (NASDAQ:PRQR)
Historical Stock Chart
From Sep 2023 to Sep 2024